These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 32146028)

  • 1. A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding.
    Madsen MK; Fisher PM; Stenbæk DS; Kristiansen S; Burmester D; Lehel S; Páleníček T; Kuchař M; Svarer C; Ozenne B; Knudsen GM
    Eur Neuropsychopharmacol; 2020 Apr; 33():71-80. PubMed ID: 32146028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
    Madsen MK; Fisher PM; Burmester D; Dyssegaard A; Stenbæk DS; Kristiansen S; Johansen SS; Lehel S; Linnet K; Svarer C; Erritzoe D; Ozenne B; Knudsen GM
    Neuropsychopharmacology; 2019 Jun; 44(7):1328-1334. PubMed ID: 30685771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.
    McCulloch DE; Madsen MK; Stenbæk DS; Kristiansen S; Ozenne B; Jensen PS; Knudsen GM; Fisher PM
    J Psychopharmacol; 2022 Jan; 36(1):74-84. PubMed ID: 34189985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals.
    Søndergaard A; Madsen MK; Ozenne B; Armand S; Knudsen GM; Fisher PM; Stenbæk DS
    Front Psychol; 2022; 13():948729. PubMed ID: 36275302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans.
    Stenbæk DS; Madsen MK; Ozenne B; Kristiansen S; Burmester D; Erritzoe D; Knudsen GM; Fisher PM
    J Psychopharmacol; 2021 Apr; 35(4):459-468. PubMed ID: 33501857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT
    Raval NR; Johansen A; Donovan LL; Ros NF; Ozenne B; Hansen HD; Knudsen GM
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study.
    Stenbaek DS; Kristiansen S; Burmester D; Madsen MK; Frokjaer VG; Knudsen GM; Fisher PM
    Hum Brain Mapp; 2019 May; 40(7):2117-2124. PubMed ID: 30633430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common HTR2A variants and 5-HTTLPR are not associated with human in vivo serotonin 2A receptor levels.
    Spies M; Nasser A; Ozenne B; Jensen PS; Knudsen GM; Fisher PM
    Hum Brain Mapp; 2020 Nov; 41(16):4518-4528. PubMed ID: 32697408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic research.
    Holze F; Madsen MK; Svarer C; Gillings N; Stenbaek DS; Rudin D; Duthaler U; Liechti ME; Fisher PM; Knudsen GM
    Eur Neuropsychopharmacol; 2024 Nov; 88():43-48. PubMed ID: 39121715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of psilocybin therapy on personality structure.
    Erritzoe D; Roseman L; Nour MM; MacLean K; Kaelen M; Nutt DJ; Carhart-Harris RL
    Acta Psychiatr Scand; 2018 Nov; 138(5):368-378. PubMed ID: 29923178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands.
    Herth MM; Petersen IN; Hansen HD; Hansen M; Ettrup A; Jensen AA; Lehel S; Dyssegaard A; Gillings N; Knudsen GM; Kristensen JL
    Nucl Med Biol; 2016 Aug; 43(8):455-62. PubMed ID: 27209485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice.
    Odland AU; Kristensen JL; Andreasen JT
    Behav Brain Res; 2021 Mar; 401():113093. PubMed ID: 33359368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective 5-HT
    Jensen AA; Halberstadt AL; Märcher-Rørsted E; Odland AU; Chatha M; Speth N; Liebscher G; Hansen M; Bräuner-Osborne H; Palner M; Andreasen JT; Kristensen JL
    Biochem Pharmacol; 2020 Jul; 177():113979. PubMed ID: 32298690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a single dose of psilocybin on behaviour, brain 5-HT
    Donovan LL; Johansen JV; Ros NF; Jaberi E; Linnet K; Johansen SS; Ozenne B; Issazadeh-Navikas S; Hansen HD; Knudsen GM
    Eur Neuropsychopharmacol; 2021 Jan; 42():1-11. PubMed ID: 33288378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.
    Kometer M; Schmidt A; Jäncke L; Vollenweider FX
    J Neurosci; 2013 Jun; 33(25):10544-51. PubMed ID: 23785166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT
    Sekssaoui M; Bockaert J; Marin P; Bécamel C
    Neuropsychopharmacology; 2024 Mar; 49(4):747-756. PubMed ID: 38212441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.
    MacLean KA; Johnson MW; Griffiths RR
    J Psychopharmacol; 2011 Nov; 25(11):1453-61. PubMed ID: 21956378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.
    Kometer M; Cahn BR; Andel D; Carter OL; Vollenweider FX
    Biol Psychiatry; 2011 Mar; 69(5):399-406. PubMed ID: 21126732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring endogenous changes in serotonergic neurotransmission with [
    da Cunha-Bang S; Ettrup A; Mc Mahon B; Skibsted AP; Schain M; Lehel S; Dyssegaard A; Jørgensen LM; Møller K; Gillings N; Svarer C; Knudsen GM
    Transl Psychiatry; 2019 Apr; 9(1):134. PubMed ID: 30975977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of small polar radiometabolites in molecular neuroimaging: A PET study with [
    Johansen A; Hansen HD; Svarer C; Lehel S; Leth-Petersen S; Kristensen JL; Gillings N; Knudsen GM
    J Cereb Blood Flow Metab; 2018 Apr; 38(4):659-668. PubMed ID: 29215308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.